Payers part of the drug-pricing problem.

Gregory Twachtman/Frontline Medical NewsFDA Commissioner Scott Gottlieb, MD, speaks in the AHIP National Plan Conference Dr. Gottlieb criticized the insurance market for profiting from rebate-based agreements and creating a host where there’s a significant disincentive for biosimilars to come quickly to marketplace. Because producers typically connect rebates to quantity, there is absolutely no motivation for plans to include biosimilars, that could price insurance providers some or all rebates through the reference biologic item, Dr Gottlieb observed.The companies, he adds, aren’t detrimental about the portal, however they aren’t enthusiastic either.. Tips for getting past technology glitches Sometimes the problems are not using the workflow adjustments or individual engagement, but using the website software program itself. Robert Steed, supervisor of it for 56-company Hendrick Supplier Network in Abilene, Tx, ran into difficulty since it was the first business for whose digital health record how the website vendor had attempted to create interfaces. Aside from the issue with the program, they experienced four different merchant project managers.